Skip to main content

NEW YORK --

Valeant Pharmaceuticals

(VRX)

said Monday it agreed to buy dermatology products maker

Medicis Pharmaceutical

(MRX)

for about $2.6 billion in cash.

Canada's Valeant will pay $44 a share for Medicis, which represents a 39% premium over Medicis' closing price Friday of $31.87.

The companies expect the merger to close early next year.

Campbell Soup

(CPB) - Get Campbell Soup Company Report

is expected by analysts Tuesday to post fiscal fourth-quarter earnings of 39 cents a share on revenue of $1.59 billion.

The New and Improved Campbell Soup Co.: Opinion

Automakers such as

General Motors

(GM) - Get General Motors Company Report

TheStreet Recommends

and

Ford

(F) - Get Ford Motor Company Report

report monthly sales results for August on Tuesday.

Pork processor

Smithfield Foods

(SFD)

is expected by analysts to post fiscal first-quarter profit of 45 cents a share on revenue of $3.16 billion.

4 Biggest Earnings Reports You Must Watch Next Week

United States Steel

(X) - Get United States Steel Corporation Report

and the United Steelworkers announced a tentative agreement Sunday on a three-year contract covering more than 16,000 workers at domestic facilities.

-- Written by Joseph Woelfel

>To contact the writer of this article, click here:

Joseph Woelfel

>To submit a news tip, send an email to:

tips@thestreet.com

.

Copyright 2012 TheStreet.com Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. AP contributed to this report.